FDA.reportPublic FDA data

glycerin 144 MG/ML / lidocaine 50 MG/ML Rectal Cream

RxCUI
1866218
RxNorm name
glycerin 144 MG/ML / lidocaine 50 MG/ML Rectal Cream
Term type
SCD
Status
Active
Updated
2026-10-26 03:56:11

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
022017
Active start
022017
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
glycerin144 MG / 1 MLglyceringlycerin
lidocaine50 MG / 1 MLlidocainelidocaine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Rectal Cream316975

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
glycerin4910
lidocaine6387

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRglycerin 144 MG/ML / lidocaine 50 MG/ML Rectal Cream1NAMES
RxNorm Nameglycerin 144 MG/ML / lidocaine 50 MG/ML Rectal Cream1NAMES
RxNorm Synonymglycerin 14.4 % / lidocaine 5 % Rectal Cream1NAMES
TTYSCD1ATTRIBUTES
SPL_SET_IDcdda9fad-1081-4041-e053-2995a90ade9e1CODES
RxCUI18662181CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 6 matching rows.

NDC11, Source, Active table
NDC11SourceActive
51316033328rxnav_ndcsyes
00573284201rxnav_historical_indirect
00573284210rxnav_historical
51316033301rxnav_historical
76168032010rxnav_historical
76168040301rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
874f6f42-2c7e-4ecd-a376-aa4d8cf67669glycerin 14.4 % / lidocaine 5 % Rectal Cream [PSN] · glycerin 144 MG/ML / lidocaine 50 MG/ML Rectal Cream [SCD] · glycerin 14.4 % / lidocaine 5 % Rectal Cream [SY]32Hemorrhoidal cream Rapid Relief with Lidocaine20190604
cdda9fad-1081-4041-e053-2995a90ade9eglycerin 14.4 % / lidocaine 5 % Rectal Cream [PSN] · glycerin 144 MG/ML / lidocaine 50 MG/ML Rectal Cream [SCD] · glycerin 14.4 % / lidocaine 5 % Rectal Cream [SY]31CVS Health Hemorrhoidal Cream Maximum Strength Lidocaine Formula20211008

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
cdda9fad-1081-4041-e053-2995a90ade9eCVS Health Hemorrhoidal Cream Maximum Strength Lidocaine FormulaCVS Pharmacy, Inc | Melaleuca, Inc.20211008
874f6f42-2c7e-4ecd-a376-aa4d8cf67669Hemorrhoidal cream Rapid Relief with LidocaineVELOCITY PHARMA LLC20190604
cf7ec2db-efba-44b3-88be-f662d2384e4aHemorrhoid relief creamVelocity Pharma LLC20190508
6a3bd8c3-e8cc-439b-b549-1c4f4f86c6d4Preparation H ® Rapid ReliefWyeth Consumer Healthcare LLC20190124

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN01BBAmidesATC1-4lidocaine
ATCS02DAAnalgesics and anestheticsATC1-4lidocaine
ATCD04ABAnesthetics for topical useATC1-4lidocaine
ATCR02ADAnesthetics, localATC1-4lidocaine
ATCC01BBAntiarrhythmics, class IbATC1-4lidocaine
ATCA06AGEnemasATC1-4glycerin
ATCS01HALocal anestheticsATC1-4lidocaine
ATCC05ADLocal anestheticsATC1-4lidocaine
ATCA06AXOther drugs for constipationATC1-4glycerin
FDASPLD000485AllergensCHEMhas_chemical_structureglycerin
FDASPLD005990GlycerolCHEMhas_chemical_structureglycerin
FDASPLN0000175682Amide Local AnestheticEPChas_epclidocaine
FDASPLN0000175426AntiarrhythmicEPChas_epclidocaine
FDASPLN0000185370Non-Standardized Chemical AllergenEPChas_epcglycerin
FDASPLN0000184306Cell-mediated ImmunityPEhas_peglycerin
FDASPLN0000175629Increased Histamine ReleasePEhas_peglycerin
FDASPLN0000185001Increased IgG ProductionPEhas_peglycerin
FDASPLN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTD005990GlycerolCHEMhas_ingredientglycerin
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine
MEDRTD002056BurnsDISEASEmay_treatlidocaine
MEDRTD003248ConstipationDISEASEmay_treatglycerin
MEDRTD003872DermatitisDISEASEmay_treatglycerin
MEDRTD003872DermatitisDISEASEmay_preventglycerin
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withglycerin
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine
MEDRTD006967HypersensitivityDISEASEci_withlidocaine
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine
MEDRTD010146PainDISEASEmay_preventlidocaine
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine
MEDRTN0000000075Stool Bulking ActivityMOAhas_moaglycerin
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000009035Emollient ActivityPEhas_peglycerin
MEDRTN0000009371Increased Large Intestinal MotilityPEhas_peglycerin
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTN0000009870Stimulation Large Intestine Fluid/Electrolyte AbsorptionPEhas_peglycerin

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH144 MG/ML / 50 MG/ML
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESPrescribable Synonymglycerin 14.4 % / lidocaine 5 % Rectal Cream
SOURCESSourceMetathesaurus FDA Structured Product Labels